Past, present, and future of hormonal therapy in recurrent endometrial cancer

References

• TrimbleELHarlanLCCleggLXStevensJLPre-operative imaging, surgery and adjuvant therapy for women diagnosed with cancer of the corpus uteri in community practice in the United StatesGynecol Oncol200596374174815721420
   PubMed Web of Science ®Google Scholar
• CreasmanWTOdicinoFMaisonneuvePCarcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological CancerInt J Gynaecol Obstet200695Suppl 1S105S14317161155
   PubMed Web of Science ®Google Scholar
• WalkerJLPiedmonteMRSpirtosNMLaparoscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group Study LAP2J Clin Oncol200927325331533619805679
   PubMed Web of Science ®Google Scholar
• MillerDFiliaciVFlemingGRandomized phase III noninferiority trial of first line chemotherapy for metastatic or recurrent endometrial carcinoma: a Gynecologic Oncology Group studyGynecol Oncol20121253771
   Web of Science ®Google Scholar
• CurranWJJrWhittingtonRPetersAJFanningJVaginal recurrences of endometrial carcinoma: the prognostic value of staging by a primary vaginal carcinoma systemInt J Radiat Oncol Biol Phys19881548038083182319
   PubMed Web of Science ®Google Scholar
• SearsJDGrevenKMHoenHMRandallMEPrognostic factors and treatment outcome for patients with locally recurrent endometrial cancerCancer1994744130313088055452
   PubMed Web of Science ®Google Scholar
• WylieJIrwinCPintilieMResults of radical radiotherapy for recurrent endometrial cancerGynecol Oncol2000771667210739692
   PubMed Web of Science ®Google Scholar
• LevineDAHoskinsWJUpdate in the management of endometrial cancerCancer J20028Suppl 1S31S4012075700
   PubMed Web of Science ®Google Scholar
• SonodaYOptimal therapy and management of endometrial cancerExpert Rev Anticancer Ther200331374712597348
   PubMedGoogle Scholar
• YangSThielKWDe GeestKLeslieKKEndometrial cancer: reviving progesterone therapy in the molecular ageDiscov Med2011126420521221955848
   PubMed Web of Science ®Google Scholar
• YangSThielKWLeslieKKProgesterone: the ultimate endometrial tumor suppressorTrends Endocrinol Metab201122414515221353793
   PubMed Web of Science ®Google Scholar
• ThigpenJTBradyMFAlvarezRDOral medroxyprogesterone acetate in the treatment of advanced or recurrent endometrial carcinoma: a dose-response study by the Gynecologic Oncology GroupJ Clin Oncol19991761736174410561210
   PubMed Web of Science ®Google Scholar
• WhitneyCWBrunettoVLZainoRJPhase II study of medroxyprogesterone acetate plus tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group studyGynecol Oncol20049214914751130
   PubMed Web of Science ®Google Scholar
• LeslieKKSillMWFischerEA phase II evaluation of gefitinib in the treatment of persistent or recurrent endometrial cancer: a Gynecologic Oncology Group studyGynecol Oncol2013129348649423438670
   PubMed Web of Science ®Google Scholar
• SinghMZainoRJFiliaciVJLeslieKKRelationship of estrogen and progesterone receptors to clinical outcome in metastatic endometrial carcinoma: a Gynecologic Oncology Group StudyGynecol Oncol2007106232533317532033
   PubMed Web of Science ®Google Scholar
• DecruzeSBGreenJAHormone therapy in advanced and recurrent endometrial cancer: a systematic reviewInt J Gynecol Cancer200717596497817442022
   PubMed Web of Science ®Google Scholar
• MarkmanMHormonal therapy of endometrial cancerEur J Cancer200541567367515763641
   PubMed Web of Science ®Google Scholar
• YangSXiaoXJiaYEpigenetic modification restores functional PR expression in endometrial cancer cellsCurr Pharm Des7192013 [Epub ahead of print.]
   Google Scholar
• AllenNETsilidisKKKeyTJMenopausal hormone therapy and risk of endometrial carcinoma among postmenopausal women in the European Prospective Investigation Into Cancer and NutritionAm J Epidemiol2010172121394140320961969
   PubMed Web of Science ®Google Scholar
• ThigpenTBradyMFHomesleyHDSoperJTBellJTamoxifen in the treatment of advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group studyJ Clin Oncol200119236436711208827
   PubMed Web of Science ®Google Scholar
• ElitLHirteHNovel strategies for systemic treatment of endometrial cancerExpert Opin Investig Drugs200091228312853
   PubMed Web of Science ®Google Scholar
• McMeekinDSGordonAFowlerJA phase II trial of arzoxifene, a selective estrogen response modulator, in patients with recurrent or advanced endometrial cancerGynecol Oncol2003901646912821343
   PubMed Web of Science ®Google Scholar
• BurkeTWWalkerCLArzoxifene as therapy for endometrial cancerGynecol Oncol20038902 Pt 2S40S4612928005
   PubMed Web of Science ®Google Scholar
• AsburyRFBrunettoVLLeeRBReidGRoceretoTFGynecologic Oncology GroupGoserelin acetate as treatment for recurrent endometrial carcinoma: a Gynecologic Oncology Group studyAm J Clin Oncol200225655756012477997
   PubMed Web of Science ®Google Scholar
• CheQLiuBYLiaoYActivation of a positive feedback loop involving IL-6 and aromatase promotes intratumoral 17beta-estradiol biosynthesis in endometrial carcinoma microenvironmentInt J Cancer12182013 [Epub ahead of print.]
   Google Scholar
• Takahashi-ShigaNUtsunomiyaHMikiYLocal biosynthesis of estrogen in human endometrial carcinoma through tumor-stromal cell interactionsClin Cancer Res200915196028603419789322
   PubMed Web of Science ®Google Scholar
• SegawaTShozuMMurakamiKAromatase expression in stromal cells of endometrioid endometrial cancer correlates with poor survivalClin Cancer Res20051162188219415788666
   PubMed Web of Science ®Google Scholar
• RosePGBrunettoVLVanLeLBellJWalkerJLLeeRBA phase II trial of anastrozole in advanced recurrent or persistent endometrial carcinoma: a Gynecologic Oncology Group studyGynecol Oncol200078221221610926805
   PubMed Web of Science ®Google Scholar
• MaBBOzaAEisenhauerEThe activity of letrozole in patients with advanced or recurrent endometrial cancer and correlation with biological markers – a study of the National Cancer Institute of Canada Clinical Trials GroupInt J Gynecol Cancer200414465065815304161
   PubMed Web of Science ®Google Scholar
• SoslowRAWethingtonSLCesariMClinicopathologic analysis of matched primary and recurrent endometrial carcinomaAm J Surg Pathol201236121771178123154767
   PubMed Web of Science ®Google Scholar
• RobertsonJFRWillsherPCWinterbottomLBlameyRWThorpeSOnapristone, a progesterone receptor antagonist, as first-line therapy in primary breast cancerEur J Cancer199935221421810448262
   PubMed Web of Science ®Google Scholar
• SchneiderCCGibbRKTaylorDDWanTGercel-TaylorCInhibition of endometrial cancer cell lines by mifepristone (RU 486)J Soc Gynecol Investig199856334338
   PubMedGoogle Scholar
• JordanVCNew insights into the metabolism of tamoxifen and its role in the treatment and prevention of breast cancerSteroids2007721382984217765940
   PubMed Web of Science ®Google Scholar
• SasakiMDhariaAOhBRTanakaYFujimotoSDahiyaRProgesterone receptor B gene inactivation and CpG hypermethylation in human uterine endometrial cancerCancer Res20016119710211196205
   PubMed Web of Science ®Google Scholar
• XiongYDowdySCGonzalez BosquetJEpigenetic-mediated upregulation of progesterone receptor B gene in endometrial cancer cell linesGynecol Oncol200599113514116024066
   PubMed Web of Science ®Google Scholar
• RenYLiuXMaDFengYZhongNDown-regulation of the progesterone receptor by the methylation of progesterone receptor gene in endometrial cancer cellsCancer Genet Cytogenet2007175210711617556066
   PubMedGoogle Scholar
• DaiDAlbitarLNguyenTLaidlerLLSinghMLeslieKKA therapeutic model for advanced endometrial cancer: systemic progestin in combination with local adenoviral-mediated progesterone receptor expressionMol Cancer Ther20054116917515657363
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Research NetworkKandothCSchultzNCherniackADIntegrated genomic characterization of endometrial carcinomaNature20134977447677323636398
   PubMed Web of Science ®Google Scholar
• LentzSSBradyMFMajorFJReidGCSoperJTHigh-dose megestrol acetate in advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group StudyJ Clin Oncol19961423573618636744
   PubMed Web of Science ®Google Scholar
• FioricaJVBrunettoVLHanjaniPPhase II trial of alternating courses of megestrol acetate and tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group studyGynecol Oncol2004921101414751131
   PubMed Web of Science ®Google Scholar